Analyzing Ucp1, we found lower expression in pancreatic (median 0.63 IQR 0.35; 1.57) and colorectal (median 0.35 IQR 0.31; 1.07) cancer patients compared to controls (median 1.26 IQR 0.92; 1.81) (p = 0.017 and p = 0.004, respectively) (Figure 3A). Here, UCP1 is linked to cancer.